Esketamine-Induced Dissociation: A Case Report.
Journal of Psychoactive Drugs November 10, 2024 Jake Scarcella, Jeffrey MacDaniels, Lucinda Coffin et al. 1 citation
Esketamine, the isolated S-enantiomer of ketamine, has been a recent breakthrough as a non-monoaminergic treatment for treatment-resistant depression (TRD). This case report explores a rare adverse event in a 41-year-old female with TRD, who, despite experiencing significant depressive improvement with esketamine, encountered a severe dissociative episode accompanied by hallucinogenic-like...